Neogenomics Cash Flow Statement (2010-2026) | NEO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	75.87M	-20.35M	-41.76M	-49.41M	-35.30M	-36.85M	-22.69M	-30.80M	-24.33M	-18.52M	-14.33M	-27.06M	-18.64M	-17.70M	-15.32M	-25.92M	-45.09M	-27.13M	-9.88M	-17.11M
Depreciation and Depletion (Quarter)	6.95M	8.18M	8.38M	8.39M	8.53M	8.97M	9.48M	9.05M	9.47M	9.35M	9.58M	9.90M	9.75M	9.62M	9.83M	9.37M	9.14M	8.80M	8.76M	8.78M
Share-based Compensation (Quarter)	4.51M	5.24M	10.06M	12.10M	3.63M	4.28M	4.66M	4.76M			6.99M	7.77M	0.10M		8.33M	10.75M	12.21M	10.31M	8.04M	9.64M
Deferred Taxes (Quarter)				3.77M	5.73M	3.29M	3.32M	3.04M	2.90M	3.44M	1.81M	0.80M	0.47M	0.24M	1.56M	0.54M	0.99M	-0.87M	2.69M	0.77M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)	0.16M	-0.00M	0.04M		0.13M	0.03M	0.03M		0.17M		7.34M	0.09M	0.09M	0.14M	0.30M		0.46M		5.94M
Asset Writedowns and Impairment (Quarter)							0.72M	0.92M	0.74M	0.04M	-0.00M	0.14M			0.50M		8.20M	7.09M
Non-cash Items (Quarter)
Cash from Operations (Quarter)	-1.39M	-7.77M	-19.78M	-29.04M	-17.00M	-16.27M	-3.69M	-12.69M	-1.55M	-5.50M	17.78M	-25.91M	13.89M	9.25M	9.80M	-25.33M	20.33M	8.88M	1.34M	-8.14M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	3.75M	8.47M	0.66M	0.66M	8.49M	8.49M	-22.81M	0.67M	8.78M	8.78M	0.68M	0.68M	8.36M	8.36M	0.68M	8.36M	8.12M	7.63M	-22.21M	7.63M
Amortization of Deferred Charges (Quarter)	0.04M	0.04M	0.04M	0.04M	0.05M	0.04M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.02M	0.01M	0.01M
Depreciation & Amortization (CF) (Quarter)	6.95M	8.18M	8.38M	8.39M	8.53M	8.97M	9.48M	9.05M	9.47M	9.35M	9.58M	9.90M	9.75M	9.62M	9.83M	9.37M	9.14M	8.80M	8.76M	8.78M
Change in Working Capital
Change in Receivables (Quarter)	2.77M	-1.32M	7.17M	-1.33M	0.48M	0.72M	7.72M	-0.87M	6.58M	7.21M	-1.41M	9.05M	6.30M	4.85M	-0.89M	0.67M	-1.06M	2.37M	4.21M	8.18M
Change in Inventory (Quarter)	-0.80M	0.45M	1.56M	0.45M	-1.98M	1.94M	0.70M	0.20M	0.69M	-0.64M	0.20M	-3.84M	3.00M	1.24M	2.29M	3.02M	4.12M	-5.63M	0.03M	1.27M
Change in Accured Expenses (Quarter)	11.18M	10.67M	-7.60M	-5.99M	4.96M	1.01M	1.85M	-7.25M	6.74M	-2.48M	-1.56M	-0.14M	-2.14M	1.28M	-3.00M	-22.96M	30.68M	-19.29M	6.88M	0.72M
Other Working Capital Changes (Quarter)	0.24M	0.43M	-9.10M	2.04M	-0.44M	2.00M	-1.89M	1.19M	1.43M	-2.49M	-7.75M	-0.06M	-0.26M	1.52M	5.62M	0.77M	-0.96M	1.84M	-1.97M	1.40M
Investing Activities
Capital Expenditures (Quarter)	35.10M	14.98M	11.99M	8.22M	10.29M	7.84M	-24.67M	1.17M	16.25M	-16.79M	-0.03M	5.58M	13.08M	10.80M	-28.45M	4.50M	6.32M	8.31M	-17.42M	5.00M
Change in Intangibles (Quarter)
Acquisitions (Quarter)	419.40M																	0.46M
Change in Acquisitions & Divestments (Quarter)	12.33M	18.48M	18.23M	36.44M	32.09M	21.29M	27.10M	40.42M	22.44M	25.09M	24.25M	20.11M	20.39M	7.28M	6.13M	8.06M	3.00M	9.00M
Cash from Investing Activities (Quarter)	-453.41M	-14.69M	-9.58M	12.05M	-6.27M	-4.20M	-1.06M	23.74M	14.95M	20.82M	17.20M	14.53M	7.31M	-3.52M	-5.47M	3.56M	-9.31M	-0.28M	-6.30M	-5.00M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)	204.61M	-6.72M	2.46M	6.06M	1.01M	2.96M	1.80M	1.38M	0.06M	1.84M	1.27M	0.82M	1.97M	1.18M	0.69M	0.95M	-202.43M	0.77M	0.43M	-0.34M
Additional items
Exchange Rate Effect (Quarter)																		0.02M
Change in Cash (Quarter)	-250.19M	-29.17M	-26.90M	-10.93M	-22.26M	-17.51M	-2.95M	12.43M	13.46M	17.16M	36.25M	-10.57M	23.17M	6.91M	5.02M	-20.82M	-191.47M	9.43M	-4.53M	-13.47M
Free Cash Flow (Quarter)	-36.49M	-22.74M	-31.76M	-37.26M	-27.29M	-24.12M	20.98M	-13.87M	-17.80M	11.29M	17.81M	-31.50M	0.81M	-1.55M	38.25M	-29.83M	14.01M	0.57M	18.77M	-13.14M
Net Cash Flow (Quarter)	-250.19M	-29.17M	-26.90M	-10.93M	-22.26M	-17.51M	-2.95M	12.43M	13.46M	17.16M	36.25M	-10.57M	23.17M	6.91M	5.02M	-20.82M	-191.42M	9.37M	-4.53M	-13.47M

Research Tools

Neogenomics Cash Flow Statement (2010-2026) | NEO

Create an account

Sign In

Reset Password